Cardiac Arrest News and Research RSS Feed - Cardiac Arrest News and Research

A cardiac arrest, also known as cardiopulmonary arrest or circulatory arrest, is the abrupt cessation of normal circulation of the blood due to failure of the heart to contract effectively during systole.
Amgen receives FDA priority review designation for Kyprolis to treat relapsed multiple myeloma

Amgen receives FDA priority review designation for Kyprolis to treat relapsed multiple myeloma

Amgen today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) of Kyprolis® (carfilzomib) for Injection for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy. [More]
Egalet announces plans to commercialize SPRIX Nasal Spray and OXAYDO tablets

Egalet announces plans to commercialize SPRIX Nasal Spray and OXAYDO tablets

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced its plans for the commercialization of SPRIX (ketorolac tromethamine) Nasal Spray and OXAYDO (oxycodone HCI, USP) tablets for oral use only –CII. [More]
NIH awards K23 grant to study effects of carbon dioxide levels after cardiac arrest

NIH awards K23 grant to study effects of carbon dioxide levels after cardiac arrest

The NIH-National Heart Lung and Blood Institute has awarded Brian W. Roberts, MD, emergency medicine physician at Cooper University Health Care and Assistant Professor of Emergency Medicine at Cooper Medical School of Rowan University (CMSRU), a Mentored Patient-Oriented Career Development grant (K23) to study post-resuscitation partial pressure of arterial carbon dioxide and neurological outcome after cardiac arrest. [More]
Egalet announces net revenues of $1.9 million for 2014

Egalet announces net revenues of $1.9 million for 2014

Egalet Corporation today reported financial results for the year ended December 31, 2014. [More]
Accidental fentanyl exposure in children can be fatal

Accidental fentanyl exposure in children can be fatal

Infants and children are at a higher risk of accidental exposure to fentanyl patches—adhesive patches used to deliver higher doses of some opiates through the skin to relieve chronic pain. [More]
Discoveries by WA research team offer further treatment hope for victims of stroke

Discoveries by WA research team offer further treatment hope for victims of stroke

A West Australian research team has made a series of discoveries which may help to minimise the damage that a stroke can cause. [More]
Meridian Health to celebrate American Heart Month, raise awareness for women's heart health

Meridian Health to celebrate American Heart Month, raise awareness for women's heart health

For the seventh year in a row, Meridian Health's Red Dress event will celebrate American Heart Month and raise awareness for women's heart health. The fun-filled, health-focused event will take place at Watermark, a chic lounge in Asbury Park. In partnership with The Heart Truth campaign, sponsored by the National Heart, Lung and Blood Institute, Meridian CardioVascular Network's Red Dress event will showcase fashions from the famous Red Dress Collection. [More]
UMHS opens Massey Emergency Critical Care Center

UMHS opens Massey Emergency Critical Care Center

They come from highway accident scenes and nursing home beds, from factories and farm fields, from suburban homes, downtown sidewalks and small community hospitals. [More]
Eight clinical researchers selected as finalists for Outstanding Investigator Award at Cardiology 2015

Eight clinical researchers selected as finalists for Outstanding Investigator Award at Cardiology 2015

Pediatric cardiology researchers and clinicians from numerous centers from around the world are gathering at the Cardiology 2015: the 18th Annual Update on Pediatric and Congenital Cardiovascular Disease conference, sponsored by The Children's Hospital of Philadelphia and Phoenix Children's Hospital on Feb. 11 to Feb. 15 in Scottsdale, Ariz. [More]
Researchers demonstrate advantages of implanted defibrillator in preventing non-ischaemic heart failure

Researchers demonstrate advantages of implanted defibrillator in preventing non-ischaemic heart failure

Sudden cardiac arrest is a possible cause of death in patients with non-ischaemic cardiac muscle weakness, i.e. a type of heart failure caused by genetics or for which no cause is known. Now, researchers at the University Department of Internal Medicine II at the MedUni Vienna (Clinical Department of Cardiology), as part of an international cooperation, have successfully demonstrated the advantages of an implanted defibrillator (ICD) as a means of prevention in patients with moderately restricted cardiac function, and that patients with the condition must be treated as carefully as patients with ischaemic heart failure which has developed following a heart attack, for example. [More]
Study: Simple blood test could predict risk of developing dementia

Study: Simple blood test could predict risk of developing dementia

Scientists at Rigshopitalet, Herlev Hospital and the University of Copenhagen identify a new biomarker that can predict the risk of developing dementia by way of a simple blood test. In the long term, this could mean better prevention and thus at least postponement of the illness and at best evading the development all together. [More]
Ohio State cardiologist answers questions relating to Hands-Only CPR

Ohio State cardiologist answers questions relating to Hands-Only CPR

When a person's heart stops beating, every second counts. However, bystanders often fear giving cardiopulmonary resuscitation (CPR) to a victim. [More]
CPR depth and rate of compressions significantly impact survival, recovery of patients

CPR depth and rate of compressions significantly impact survival, recovery of patients

The depth of chest compressions and the rate at which they were applied make a significant impact on survival and recovery of patients, a review of research by UT Southwestern Medical Center Emergency Medicine physicians shows. [More]
ISP shows promise in stopping fatal arrhythmias after heart attack

ISP shows promise in stopping fatal arrhythmias after heart attack

Case Western Reserve's chemical compound aimed at restoring spinal cord function may have an additional purpose: stopping potentially fatal arrhythmias after heart attack. [More]
AP39 compound could help lower heart rate, blood pressure, and blood vessel stiffness

AP39 compound could help lower heart rate, blood pressure, and blood vessel stiffness

A gas that gives rotten eggs their distinctive odour could one day form the basis of new cardiovascular therapies. [More]
Kaleo, CHMI partner to reduce prescription drug-related deaths

Kaleo, CHMI partner to reduce prescription drug-related deaths

Kaleo, a privately-held pharmaceutical company, today announced a national strategic partnership with the Clinton Health Matters Initiative, an initiative of the Clinton Foundation, that will help support its goal of cutting prescription drug-related deaths in half, saving approximately 10,000 lives over five years. [More]
Understanding heart mutations that cause sudden cardiac arrest

Understanding heart mutations that cause sudden cardiac arrest

New biosciences research at the University of Kent could point the way to greater understanding of the heart mutations that cause sudden cardiac arrest. [More]
Cardiac arrest associated with high mortality even in the world of Star Trek

Cardiac arrest associated with high mortality even in the world of Star Trek

The Star Trek universe is one of the most popular pieces of science fiction entertainment. Lots of the technologies seen in the TV and cinema episodes featuring Captain Kirk, Mr Spock or Captain Picard were once regarded as futuristic, but have now become reality - with examples including wireless communication or portable computers. In a recent study by the University Department of Emergency Medicine at the MedUni Vienna, the make-believe future of the human race depicted in this series has been used to investigate the frequency and mortality of cardiac arrests in the 24th century. [More]
LSDF announces $1.2 million in grants to foster advancement of promising health-related technologies

LSDF announces $1.2 million in grants to foster advancement of promising health-related technologies

The Life Sciences Discovery Fund today announced $1.2 million in Proof of Concept grants to Washington-based organizations to foster the advancement of promising health-related technologies to commercial products. Also announced were two commercialization-focused awards, totaling $600,000, through a new funding program requiring external cash matching. [More]
Lilly receives FDA approval for CYRAMZA (ramucirumab)

Lilly receives FDA approval for CYRAMZA (ramucirumab)

Eli Lilly and Company has received its third U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab). [More]
Advertisement
Advertisement